E. Corcoran Biography and Net Worth

Director of Phibro Animal Health

E. Thomas Corcoran, Director. Mr. Corcoran has been a director since May 2008. Mr. Corcoran also serves as Chairman of the Audit Committee. Mr. Corcoran joined Fort Dodge Animal Health, a division of Wyeth, Inc., as its President in 1985. Wyeth was a research-based corporation with businesses focused on human health and animal health. Mr. Corcoran served on the Management, the Operations, the Legal, and the Human Resources and Benefits committees of Wyeth until his retirement in March 2008. From 2010 until 2016, Mr. Corcoran was a director of Putney, Inc., a pet pharmaceutical company. Mr. Corcoran also served as the Chairman of the Animal Health Institute, an industry organization advocating for animal health issues, including efficient and effective FDA, USDA and EPA regulatory and approval processes. Mr. Corcoran serves on the Board of Trustees of the University of South Alabama. Mr. Corcoran is a recipient of the Animal Pharm Lifetime Achievement Award, the Banfield Industry Leadership Award, the Lifetime Achievement Award from the American Veterinary Distributors Association and the Industry Leadership Award from the Kansas City Animal Health Corridor. Mr. Corcoran is a recipient of the Distinguished Alumni Award from the University of South Alabama. Mr. Corcoran is qualified to serve on our Board of Directors due to his extensive experience and executive leadership in the animal health industry.

What is E. Thomas Corcoran's net worth?: The estimated net worth of E. Thomas Corcoran is at least $584,750.00 as of September 4th, 2024. Mr. Corcoran owns 25,000 shares of Phibro Animal Health stock worth more than $584,750 as of November 21st. This net worth estimate does not reflect any other assets that Mr. Corcoran may own. Learn More about E. Thomas Corcoran's net worth.
How do I contact E. Thomas Corcoran?: The corporate mailing address for Mr. Corcoran and other Phibro Animal Health executives is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. Phibro Animal Health can also be reached via phone at (201) 329-7300 and via email at [email protected]. Learn More on E. Thomas Corcoran's contact information.
Has E. Thomas Corcoran been buying or selling shares of Phibro Animal Health?: E. Thomas Corcoran has not been actively trading shares of Phibro Animal Health during the last quarter. Most recently, on Wednesday, September 4th, E Thomas Corcoran bought 5,000 shares of Phibro Animal Health stock. The stock was acquired at an average cost of $20.02 per share, with a total value of $100,100.00. Following the completion of the transaction, the director now directly owns 25,000 shares of the company's stock, valued at $500,500. Learn More on E. Thomas Corcoran's trading history.
Who are Phibro Animal Health's active insiders?: Phibro Animal Health's insider roster includes Jack Bendheim (Chairman), and E. Corcoran (Director). Learn More on Phibro Animal Health's active insiders.
Are insiders buying or selling shares of Phibro Animal Health?: During the last year, Phibro Animal Health insiders bought shares 1 times. They purchased a total of 5,000 shares worth more than $100,100.00. The most recent insider tranaction occured on September, 4th when Director E Thomas Corcoran bought 5,000 shares worth more than $100,100.00. Insiders at Phibro Animal Health own 50.1% of the company. Learn More about insider trades at Phibro Animal Health.
Information on this page was last updated on 9/4/2024.

E. Thomas Corcoran Insider Trading History at Phibro Animal Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/4/2024	Buy	5,000	$20.02	$100,100.00	25,000
8/30/2021	Buy	5,000	$23.68	$118,400.00	20,000
8/30/2019	Buy	5,000	$21.21	$106,050.00	15,000
5/19/2016	Buy	5,000	$18.14	$90,700.00	10,000
4/22/2014	Buy	5,000	$16.70	$83,500.00

E. Thomas Corcoran Buying and Selling Activity at Phibro Animal Health

Phibro Animal Health Company Overview

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

Today's Range

Now: $23.39

$23.09

$23.64

50 Day Range

MA: $23.08

$20.89

$25.55

2 Week Range

Now: $23.39

$9.49

$25.98

Volume

228,844 shs

Average Volume

182,567 shs

Market Capitalization

$947.30 million

P/E Ratio

54.40

Dividend Yield

2.02%

Beta

0.51

Trump’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW